doi: 10.3389/fmed.2026.1752341 Received 23 November 2025 Revised 04 April 2026 Accepted 10 April 2026 Published 29 April 2026 Volume 13 - 2026 Edited by Wei Liu, Huazhong University of Science and Technology, China Reviewed by Jheng-Yan Wu, Chi Mei Medical Center, Taiwan Jennifer Teske, University of Arizona, United States Updates Copyright 2026 Fang, Zhu, Rao and Liu
Future studies with long-term treatment would be helpful to determine whether chronic MC4R agonism may result in the formation of new pro-social structural changes or even lead to reversal of existing structural abnormalities
Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that helps people with Type 2 diabetes manage their blood sugar levels while also curbing their appetite
Its not like you stop drinking for the week that you have the side effects, and then you go right back to it
Apply a small amount of GlowLift Cream evenly across face and neck
Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma